Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This post-approval study is being conducted to examine the performance of the STAR Ankle under actual conditions of use.
This investigation is a prospective, multi-center, single-arm study. 98 subjects are to be enrolled in this clinical investigation. Enrolled subjects will be assessed at Pre-Operative, Operative/Discharge, and at 6 Weeks, 6, 12, and 24 Months after the index procedure. Safety, efficacy, and effectiveness analyses will be performed for all follow-up points during the study.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Single | Other | Device: Scandinavian Total Ankle Replacement System (STAR Ankle) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Scandinavian Total Ankle Replacement System (STAR Ankle) | Device | For total ankle replacement |
|
| Measure | Description | Time Frame |
|---|---|---|
| Primary Endpoint | The primary objective of this study is to examine the performance of the STARâ„¢ Ankle under actual conditions of use, employing the approved instructions for use, labeling, and instrumentation. The principal endpoint consists of evaluating the safety and effectiveness of the STARâ„¢ Ankle. Overall patient success is defined as:
| 2 years |
| Measure | Description | Time Frame |
|---|---|---|
| Secondary Endpoints | In addition to the principal endpoint, information on the following efficacy outcomes will be assessed:
The following radiographic endpoints will be assessed by anterior/posterior and lateral radiographs by the treating surgeon and an independent radiographic reviewer:
|
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Stefan Maartense, MD | Stryker Nordic | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The CORE Institute | Phoenix | Arizona | 85023 | United States | ||
| Cedars Sinai Medical Center |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 2 years |
| Los Angeles |
| California |
| 90048 |
| United States |
| Palo Alto Medical Research Foundation (Sutter Health) | Palo Alto | California | 94301 | United States |
| Kaiser Permanente | San Francisco | California | 94118 | United States |
| William Beaumont Hospital | Royal Oak | Michigan | 48085 | United States |
| Reno Orthopaedic Center | Reno | Nevada | 89503 | United States |
| Kenneth Mroczek, MD-NYU | New York | New York | 10003 | United States |
| University of Pennsylvania Health Systems-PA Foot and Ankle Surgeons | Philadelphia | Pennsylvania | 19106 | United States |
| Center for Foot and Ankle Restoration | Dallas | Texas | 75231 | United States |
| ID | Term |
|---|---|
| D001172 | Arthritis, Rheumatoid |
| D010003 | Osteoarthritis |
| ID | Term |
|---|---|
| D001168 | Arthritis |
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D012216 | Rheumatic Diseases |
| D003240 | Connective Tissue Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
Not provided
Not provided